Monograph Details
|
|
Dermatological Disorders
> Miscellaneous dermatological conditions
|
|
LUSTRA |
| Manufacturer |
|
Medicis Pharmaceuticals Corp |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Depigmenting agent. |
| Generic Name |
|
Hydroquinone 4%; crm; contains sulfites. |
| Also |
|
• LUSTRA-AF
|
| Indications |
|
UV-induced skin dyschromia and discoloration due to hormonal changes or skin trauma. |
| Children |
|
Not recommended. |
| Adults |
|
Apply to affected areas twice daily. Discontinue if lightening effect does not occur after 2 months. |
| Precautions |
|
Do skin sensitivity test before use; do not use if itching, vesicle formation or excessive inflammation occurs. Avoid sun and UV light. Not for use as a sunscreen. Avoid eyes. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Contact dermatitis. |
| How Supplied |
|
Both—1oz, 2oz |
|
|
|
|
